Transparency Statement Thomas and Landon Clay

14 Jan 2016

Regulated Information - Transparency Statement

 

Leuven, Belgium, 14 January 2016 – Pursuant to Belgian transparency legislation (Law of 2 May 2007), ThromboGenics NV (Euronext Brussels: THR) received a transparency notification on 13 January 2016 from Mr Thomas M Clay and from Mr Landon T. Clay and controlled entities (East Hill Hedge Fund LLC, Monadnock Charitable Lead Annuity Trust, Clay Fellowships Charitable Trust en The Clay Mathematics Institute, Inc., or the 'East Hill Management Company LLC).

Thomas M. Clay notified that on 8 January 2016, the ThromboGenics shares controlled by himself have risen to 2,790,062 shares, or 7.73% of the current 36,094,349 outstanding ThromboGenics shares.

 Landon T. Clay notified that on 8 January 2016 the ThromboGenics shares controlled by himself and entities under his control have fallen below 3% of the current 36,094,349 outstanding ThromboGenics shares, being the threshold under which no participations need to be made public.

 On 14 January 2016, based on all received transparency declarations received, ThromboGenics NV is aware of the following participations:

 

Shareholder

number of securities

% of voting rights

Mr Thomas M. Clay and entities controlled by him

2.790.062

7.73%

Norges Bank

1,065,605

2.95%

Baron Philippe Vlerick and entities controlled by him

2,324,719

6.44%